Correlation Between Day One and Cytokinetics

Can any of the company-specific risk be diversified away by investing in both Day One and Cytokinetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Cytokinetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Cytokinetics, you can compare the effects of market volatilities on Day One and Cytokinetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Cytokinetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Cytokinetics.

Diversification Opportunities for Day One and Cytokinetics

0.53

Correlation Coefficient

Day One  Cytokinetics

Very weak diversification

The 3 months correlation between Day and Cytokinetics is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Cytokinetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytokinetics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Cytokinetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytokinetics has no effect on the direction of Day One i.e., Day One and Cytokinetics go up and down completely randomly.

Pair Corralation between Day One and Cytokinetics

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Cytokinetics. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.11 times less risky than Cytokinetics. The stock trades about -0.34 of its potential returns per unit of risk. The Cytokinetics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  4,946  in Cytokinetics on December 2, 2024 and sell it today you would lose (346.00) from holding Cytokinetics or give up 7.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Cytokinetics

Day One Biopharmaceu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cytokinetics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cytokinetics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Day One and Cytokinetics

The main advantage of trading using opposite Day One and Cytokinetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Cytokinetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will offset losses from the drop in Cytokinetics' long position.

The idea behind Day One Biopharmaceuticals and Cytokinetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.